The investigator collected, verified completed diary cards, and qualified staff interviewed participants to assess the occurrence of unsolicited AEs, serious adverse events (SAEs), and adverse events of special interest (AES)
IH NMR (D20, 300 MHz) 8(ppm): 8.55 (s, IH), 7.45 (d, 2H), 6.5 (d, 2H), 4.6 (m, 2H), 4.45 (t, IH), 4.35 (bs, 2H), 4.2 (m, IH), 4.1 (s, IH), 4.05 (m, IH), 2.9 (t, 2H), 2.75-2.4 (m, 6H), 2.3 (m, 2H), 2.2-1.9 (m, 2H), 1.8-1.4 (m, 2H), 1.2 (m, 2H), 1.3 (s, 3H), 1.2 (s, 3H)
En caso de tratamiento mdico, consulte con su terapeuta
PMC 3695395
It is also important to note that products sold as AOD 9604 are often presented as injectable preparations, though some are marketed in oral or topical forms with unknown absorption and unverified quality